Why Consider Aspirin for the Treatment of Vestibular Schwannoma? A Brief Review and Randomized, Double‐Blind, Placebo‐Controlled Study Proposal

Why Consider Aspirin for the Treatment of Vestibular Schwannoma? A Brief Review and Randomized, Double‐Blind, Placebo‐Controlled Study Proposal

ABSTRACT Objective The primary objective of this study is to review the evidence for aspirin use to prevent the growth of vestibular schwannomas (VS) and to propose a prospective trial to determine the progression‐free survival of VS patients after up to 42 months of treatment with aspirin. Secondar...

Full description

Saved in:
Bibliographic Details
Main Authors: D. Bradley Welling, Brian A. Neff, Fred F. Telischi, Neil Patel, Konstantina M. Stankovic
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Laryngoscope Investigative Otolaryngology
Subjects:
aspirin
double‐blinded prospective randomized placebo controlled trial
review
vestibular schwannoma
Online Access:https://doi.org/10.1002/lio2.70121
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items